Bibliography

Found 29 results

Filters: Author is McCutchan, John Allen [Clear All Filters]

2022

Watson CWei-Ming, Kamalyan L, Tang B, Hussain MA, Cherner M, Mindt MRivera, Byrd DA, Franklin DR, Collier AC, Clifford DB, et al. Ethnic/Racial Disparities in Longitudinal Neurocognitive Decline in People With HIV. J Acquir Immune Defic Syndr. 2022 ;90(1):97-105.

2019

Perez-Valero I, Ellis RJ, Heaton RK, Deutsch R, Franklin D, Clifford DB, Collier AC, Gelman B, Marra C, McCutchan JA, et al. Cerebrospinal fluid viral escape in aviremic HIV-infected patients receiving antiretroviral therapy: prevalence, risk factors and neurocognitive effects. AIDS. 2019 ;33(3):475-481.

Saloner R, Marquine MJ, Sundermann EE, Hong S, McCutchan JA, Ellis RJ, Heaton RK, Grant I, Cherner M. COMT Val158Met Polymorphism, Cardiometabolic Risk, and Nadir CD4 Synergistically Increase Risk of Neurocognitive Impairment in Men Living With HIV. Journal of Acquired Immune Deficiency Syndromes . 2019 ;81.

Livelli A, Vaida F, Ellis RJ, Ma Q, Ferrara M, Clifford DB, Collier AC, Gelman B, Marra CM, McArthur JC, et al. Correlates of HIV RNA concentrations in cerebrospinal fluid during antiretroviral therapy: a longitudinal cohort study. Lancet HIV. 2019 ;6(7):e456-e462.

Saloner R, Campbell LM, Serrano V, Montoya JL, Pasipanodya E, Paolillo EW, Franklin D, Ellis RJ, Letendre S, Collier AC, et al. Neurocognitive SuperAging in Older Adults Living With HIV: Demographic, Neuromedical and Everyday Functioning Correlates. Journal of the International Neuropsychological Society [Internet]. 2019 . Available from: https://www.cambridge.org/core/terms. https://doi.org/10.1017/S1355617719000018

2014

Grant I, Franklin D, Deutsch R, Woods SPaul, Vaida F, Ellis RJ, Letendre S, Marcotte TD, Atkinson JH, Collier AC, et al. Asymptomatic HIV-associated neurocognitive impairment increases risk for symptomatic decline. Neurology. 2014 ;82(23):2055-62.

Ferrara M, Umlauf A, Sanders C, Meyer JM, McCutchan JA, Duarte NA, Atkinson JH, Grant I, Ellis RJ. The concomitant use of second-generation antipsychotics and long-term antiretroviral therapy may be associated with increased cardiovascular risk. Psychiatry Res. 2014 ;218(1-2):201-8.

2013

Morgan EE, Woods SPaul, Letendre S, Franklin D, Bloss C, Goate A, Heaton RK, Collier AC, Marra CM, Gelman B, et al. Apolipoprotein E4 genotype does not increase risk of HIV-associated neurocognitive disorders. J Neurovirol. 2013 ;19(2):150-6.

Sakamoto M, Marcotte TD, Umlauf A, Franklin D, Heaton RK, Ellis RJ, Letendre S, Alexander T, McCutchan JA, Morgan EE, et al. Concurrent classification accuracy of the HIV dementia scale for HIV-associated neurocognitive disorders in the CHARTER Cohort. J Acquir Immune Defic Syndr. 2013 ;62(1):36-42.

Nguyen A, Rossi S, Croteau D, Best BM, Clifford DB, Collier AC, Gelman B, Marra C, McArthur JC, McCutchan JA, et al. Etravirine in CSF is highly protein bound. J Antimicrob Chemother. 2013 ;68(5):1161-8.

Fennema-Notestine C, Ellis RJ, Archibald SL, Jernigan TL, Letendre S, Notestine RJ, Taylor MJ, Theilmann RJ, Julaton MD, Croteau D, et al. Increases in brain white matter abnormalities and subcortical gray matter are linked to CD4 recovery in HIV infection. J Neurovirol. 2013 ;19(4):393-401.

Marra CM, Deutsch R, Collier AC, Morgello S, Letendre S, Clifford DB, Gelman B, McArthur JC, McCutchan JA, Simpson DM, et al. Neurocognitive impairment in HIV-infected individuals with previous syphilis. Int J STD AIDS. 2013 ;24(5):351-5.

2012

Croteau D, Best BM, Letendre S, Rossi SS, Ellis RJ, Clifford DB, Collier AC, Gelman BB, McArthur JC, McCutchan JAllen, et al. Lower than expected maraviroc concentrations in cerebrospinal fluid exceed the wild-type CC chemokine receptor 5-tropic HIV-1 50% inhibitory concentration. AIDS. 2012 ;26(7):890-3.

2006

Pillai SK, Pond SLK, Liu Y, Good BM, Strain MC, Ellis RJ, Letendre S, Smith DM, Günthard HF, Grant I, et al. Genetic attributes of cerebrospinal fluid-derived HIV-1 env. Brain: A Journal of Neurology [Internet]. 2006 ;129:1872-83. Available from: http://www.ncbi.nlm.nih.gov/pubmed/16735456

Langford D, Marquie-Beck J, de Almeida SM, Lazzaretto D, Letendre S, Grant I, McCutchan JA, Masliah E, Ellis RJ. Relationship of antiretroviral treatment to postmortem brain tissue viral load in human immunodeficiency virus-infected patients. Journal of Neurovirology [Internet]. 2006 ;12:100-7. Available from: http://www.ncbi.nlm.nih.gov/pubmed/16798671

Monteiro de Almeida S, Letendre S, Zimmerman J, Kolakowski S, Lazzaretto D, McCutchan JA, Ellis RJ. Relationship of CSF leukocytosis to compartmentalized changes in MCP-1/CCL2 in the CSF of HIV-infected patients undergoing interruption of antiretroviral therapy. Journal of Neuroimmunology [Internet]. 2006 ;179:180-5. Available from: http://www.ncbi.nlm.nih.gov/pubmed/16901548

2005

Schweinsburg BC, Taylor MJ, Alhassoon OM, Gonzalez RG, Brown GG, Ellis RJ, Letendre S, Videen JS, McCutchan JA, Patterson TL, et al. Brain mitochondrial injury in human immunodeficiency virus-seropositive (HIV+) individuals taking nucleoside reverse transcriptase inhibitors. Journal of NeuroVirology [Internet]. 2005 ;11(4):356-64. Available from: http://www.ncbi.nlm.nih.gov/pubmed/16206458

Monteiro de Almeida S, Letendre S, Zimmerman J, Lazzaretto D, McCutchan JA, Ellis RJ. Dynamics of monocyte chemoattractant protein type one (MCP-1) and HIV viral load in human cerebrospinal fluid and plasma. Journal of Neuroimmunology [Internet]. 2005 ;169(1-2):144-52. Available from: http://www.ncbi.nlm.nih.gov/pubmed/16182380

Letendre S, Cherner M, Ellis RJ, Marquie-Beck J, Gragg B, Marcotte TD, Heaton RK, McCutchan JA, Grant I. The effects of hepatitis C, HIV, and methamphetamine dependence on neuropsychological performance: biological correlates of disease. AIDS (London, England) [Internet]. 2005 ;19 Suppl 3:S72-8. Available from: http://www.ncbi.nlm.nih.gov/pubmed/16251831

Strain MC, Letendre S, Pillai SK, Russell T, Ignacio CC, Good BM, Smith DM, Wolinsky SM, Furtado M, Marquie-Beck J, et al. Genetic composition of human immunodeficiency virus type 1 in cerebrospinal fluid and blood without treatment and during failing antiretroviral therapy. Journal of Virology [Internet]. 2005 ;79(3):1772-88. Available from: http://www.ncbi.nlm.nih.gov/pubmed/15650202

2004

Archibald SL, Masliah E, Fennema-Notestine C, Marcotte TD, Ellis RJ, McCutchan JA, Heaton RK, Grant I, Mallory ME, Miller A, et al. Correlation of in vivo neuroimaging abnormalities with postmortem human immunodeficiency virus encephalitis and dendritic loss. Archives of Neurology [Internet]. 2004 ;61(3):369-76. Available from: http://www.ncbi.nlm.nih.gov/pubmed/15023814

Letendre S, McCutchan JA, Childers ME, Woods SPaul, Lazzaretto D, Heaton RK, Grant I, Ellis RJ, HNRC. Enhancing antiretroviral therapy for human immunodeficiency virus cognitive disorders. Annals of Neurology [Internet]. 2004 ;56:416-23. Available from: http://www.ncbi.nlm.nih.gov/pubmed/15349869

Heaton RK, Marcotte TD, Rivera-Mindt M, Sadek J, Moore D, Bentley H, McCutchan JA, Reicks C, Grant I, HNRC. The impact of HIV-associated neuropsychological impairment on everyday functioning. Journal of the International Neuropsychological Society [Internet]. 2004 ;10(3):317-31. Available from: http://www.ncbi.nlm.nih.gov/pubmed/15147590

2003

Langford D, Adame A, Grigorian A, Grant I, McCutchan JA, Ellis RJ, Marcotte TD, Masliah E, HNRC. Patterns of selective neuronal damage in methamphetamine-user AIDS patients. Journal of Acquired Immune Deficiency Syndromes (1999) [Internet]. 2003 ;34(5):467-74. Available from: http://www.ncbi.nlm.nih.gov/pubmed/14657756

Marcotte TD, Deutsch R, McCutchan JA, Moore D, Letendre S, Ellis RJ, Wallace MR, Heaton RK, Grant I, HNRC. Prediction of incident neurocognitive impairment by plasma HIV RNA and CD4 levels early after HIV seroconversion. Archives of Neurology [Internet]. 2003 ;60(10):1406-12. Available from: http://www.ncbi.nlm.nih.gov/pubmed/14568811

Pages